Skip to content
Home/Companies/Pharma/NorthX Biologics

NorthX Biologics

Pharma·Sweden·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns NorthX Biologics?

NorthX Biologics is a Swedish Pharma company, currently owned by Flerie since 2021.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
Flerie
Investor
Flerie
Flerie Invest · 2011 · Life Sciences VC

Key facts

HQSweden
SectorPharma
StatusActive

More from Flerie Invest

Other portfolio companies in the same fund.

Frontier Biosolutions
Active
PharmaGermany· 2023
Mendus
Active
BiotechSweden· 2023
A3P Biomedical
Exited 2025
BiotechSweden· 2022
Alder Therapeutics
Active
BiotechSweden· 2022
AnaCardio
Active
BiotechSweden· 2022
Bohus Biotech
Active
PharmaSweden· 2022

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns NorthX Biologics?

NorthX Biologics is currently owned by Flerie, through Flerie Invest, since 2021.

When did Flerie acquire NorthX Biologics?

Flerie acquired NorthX Biologics in 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue